File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/pmic.200900611
- Scopus: eid_2-s2.0-77950657284
- PMID: 20127690
- WOS: WOS:000277253200010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Proteomics of drug resistance in candida glabrata biofilms
Title | Proteomics of drug resistance in candida glabrata biofilms | ||||
---|---|---|---|---|---|
Authors | |||||
Keywords | 2-D DIGE Biofilm Candida glabrata Microbiology Stress response | ||||
Issue Date | 2010 | ||||
Publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/proteomics | ||||
Citation | Proteomics, 2010, v. 10 n. 7, p. 1444-1454 How to Cite? | ||||
Abstract | Candida glabrata is a fungal pathogen that causes a variety of mucosal and systemic infections among compromised patient populations with higher mortality rates. Previous studies have shown that biofilm mode of the growth of the fungus is highly resistant to antifungal agents compared with the free-floating or planktonic mode of growth. Therefore, in the present study, we used 2-D DIGE to evaluate the differential proteomic profiles of C. glabrata under planktonic and biofilm modes of growth. Candida glabrata biofilms were developed on polystyrene surfaces and age-matched planktonic cultures were obtained in parallel. Initially, biofilm architecture, viability, and antifungal susceptibility were evaluated. Differentially expressed proteins more than 1.5-fold in DIGE analysis were subjected to MS/MS. The transcriptomic regulation of these biomarkers was evaluated by quantitative real-time PCR. Candida glabrata biofilms were highly resistant to the antifungals and biocides compared with the planktonic mode of growth. Candida glabrata biofilm proteome when compared with its planktonic proteome showed upregulation of stress response proteins, while glycolysis enzymes were downregulated. Similar trend could be observed at transcriptomic level. In conclusion, C. glabrata biofilms possess higher amount of stress response proteins, which may potentially contribute to the higher antifungal resistance seen in C. glabrata biofilms. © 2010 WILEY-VCH Verlag GmbH & Co. KGaA. | ||||
Persistent Identifier | http://hdl.handle.net/10722/154605 | ||||
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 1.011 | ||||
ISI Accession Number ID |
Funding Information: We thank Alan Wong, Lawrence Luk, and Priscilla Leung for technical assistance and Dr. Trevor Lane for editorial assistance. This work was supported by the Hong Kong Research Grants Council, RGC no. HKU 7624/06M. | ||||
References | |||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jayampath Seneviratne, C | en_HK |
dc.contributor.author | Wang, Y | en_HK |
dc.contributor.author | Jin, L | en_HK |
dc.contributor.author | Abiko, Y | en_HK |
dc.contributor.author | Samaranayake, LP | en_HK |
dc.date.accessioned | 2012-08-08T08:26:28Z | - |
dc.date.available | 2012-08-08T08:26:28Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Proteomics, 2010, v. 10 n. 7, p. 1444-1454 | en_HK |
dc.identifier.issn | 1615-9853 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/154605 | - |
dc.description.abstract | Candida glabrata is a fungal pathogen that causes a variety of mucosal and systemic infections among compromised patient populations with higher mortality rates. Previous studies have shown that biofilm mode of the growth of the fungus is highly resistant to antifungal agents compared with the free-floating or planktonic mode of growth. Therefore, in the present study, we used 2-D DIGE to evaluate the differential proteomic profiles of C. glabrata under planktonic and biofilm modes of growth. Candida glabrata biofilms were developed on polystyrene surfaces and age-matched planktonic cultures were obtained in parallel. Initially, biofilm architecture, viability, and antifungal susceptibility were evaluated. Differentially expressed proteins more than 1.5-fold in DIGE analysis were subjected to MS/MS. The transcriptomic regulation of these biomarkers was evaluated by quantitative real-time PCR. Candida glabrata biofilms were highly resistant to the antifungals and biocides compared with the planktonic mode of growth. Candida glabrata biofilm proteome when compared with its planktonic proteome showed upregulation of stress response proteins, while glycolysis enzymes were downregulated. Similar trend could be observed at transcriptomic level. In conclusion, C. glabrata biofilms possess higher amount of stress response proteins, which may potentially contribute to the higher antifungal resistance seen in C. glabrata biofilms. © 2010 WILEY-VCH Verlag GmbH & Co. KGaA. | en_HK |
dc.language | eng | en_US |
dc.publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/proteomics | en_HK |
dc.relation.ispartof | Proteomics | en_HK |
dc.subject | 2-D DIGE | en_HK |
dc.subject | Biofilm | en_HK |
dc.subject | Candida glabrata | en_HK |
dc.subject | Microbiology | en_HK |
dc.subject | Stress response | en_HK |
dc.subject.mesh | Biofilms | en_US |
dc.subject.mesh | Candida Glabrata - Drug Effects - Genetics - Metabolism - Physiology | en_US |
dc.subject.mesh | Drug Resistance, Fungal | en_US |
dc.subject.mesh | Electrophoresis, Gel, Two-Dimensional | en_US |
dc.subject.mesh | Gene Expression Profiling | en_US |
dc.subject.mesh | Polymerase Chain Reaction | en_US |
dc.subject.mesh | Proteomics - Methods | en_US |
dc.subject.mesh | Stress, Physiological | en_US |
dc.title | Proteomics of drug resistance in candida glabrata biofilms | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Jayampath Seneviratne, C: jaya@hku.hk | en_HK |
dc.identifier.email | Wang, Y: yuwanghk@hku.hk | en_HK |
dc.identifier.email | Jin, L: ljjin@hkucc.hku.hk | en_HK |
dc.identifier.email | Samaranayake, LP: lakshman@hku.hk | en_HK |
dc.identifier.authority | Jayampath Seneviratne, C=rp01372 | en_HK |
dc.identifier.authority | Wang, Y=rp00239 | en_HK |
dc.identifier.authority | Jin, L=rp00028 | en_HK |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/pmic.200900611 | en_HK |
dc.identifier.pmid | 20127690 | - |
dc.identifier.scopus | eid_2-s2.0-77950657284 | en_HK |
dc.identifier.hkuros | 170947 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77950657284&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 10 | en_HK |
dc.identifier.issue | 7 | en_HK |
dc.identifier.spage | 1444 | en_HK |
dc.identifier.epage | 1454 | en_HK |
dc.identifier.eissn | 1615-9861 | - |
dc.identifier.isi | WOS:000277253200010 | - |
dc.publisher.place | Germany | en_HK |
dc.relation.project | Candida biofilms: molecular mechanisms and clinical implications | - |
dc.identifier.scopusauthorid | Jayampath Seneviratne, C=6701897753 | en_HK |
dc.identifier.scopusauthorid | Wang, Y=34973733700 | en_HK |
dc.identifier.scopusauthorid | Jin, L=7403328850 | en_HK |
dc.identifier.scopusauthorid | Abiko, Y=23491243700 | en_HK |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_HK |
dc.customcontrol.immutable | csl 150127 | - |
dc.identifier.issnl | 1615-9853 | - |